BTW
Boston Trust Walden Portfolio holdings
AUM
$14B
This Quarter Return
-1.45%
1 Year Return
+12.58%
3 Year Return
+52.97%
5 Year Return
+115.22%
10 Year Return
+284.47%
AUM
$13.7B
AUM Growth
+$13.7B
(-4%)
Cap. Flow
-$126M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
17.45%
Holding
389
New
10
Increased
96
Reduced
194
Closed
17
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$54.1M |
| 2 |
Antero Midstream
AM
|
$51.3M |
| 3 |
Procter & Gamble
PG
|
$38.4M |
| 4 |
NetApp
NTAP
|
$38.4M |
| 5 |
Amazon
AMZN
|
$35.6M |
Top Sells
| 1 |
Globus Medical
GMED
|
$51.3M |
| 2 |
Waters Corp
WAT
|
$47.8M |
| 3 |
Corcept Therapeutics
CORT
|
$35.9M |
| 4 |
Flowers Foods
FLO
|
$29.9M |
| 5 |
Packaging Corp of America
PKG
|
$29.5M |
Sector Composition
| 1 | Technology | 22.64% |
| 2 | Financials | 16.75% |
| 3 | Healthcare | 14.64% |
| 4 | Industrials | 13.63% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Travelers Companies
TRV
$61.1B
| $684K | 0.01% | 2,586 | – | – |
|
302
Boston Scientific
BSX
$156B
| $671K | ﹤0.01% | 6,656 -3,275 | -33% | -$330K |
|
303
Vanguard Total World Stock ETF
VT
$51.6B
| $649K | ﹤0.01% | 5,601 | – | – |
|
304
Carrier Global
CARR
$55.5B
| $646K | ﹤0.01% | 10,187 | – | – |
|
305
L3Harris
LHX
$51.9B
| $598K | ﹤0.01% | 2,855 -274 | -9% | -$57.4K |
|
306
iShares MSCI USA Quality Factor ETF
QUAL
$54.2B
| $592K | ﹤0.01% | 3,465 -125 | -3% | -$21.4K |
|
307
Sherwin-Williams
SHW
$91.2B
| $585K | ﹤0.01% | 1,674 | – | – |
|
308
HCA Healthcare
HCA
$94.5B
| $582K | ﹤0.01% | 1,683 -85 | -5% | -$29.4K |
|
309
Wabtec
WAB
$33.1B
| $581K | ﹤0.01% | 3,201 +1 | +0% | +$181 |
|
310
Goldman Sachs
GS
$226B
| $576K | ﹤0.01% | 1,054 | – | – |
|
311
Salesforce
CRM
$245B
| $552K | ﹤0.01% | 2,056 | – | – |
|
312
Texas Instruments
TXN
$184B
| $542K | ﹤0.01% | 3,018 -25,670 | -89% | -$4.61M |
|
313
CSX Corp
CSX
$60.6B
| $539K | ﹤0.01% | 18,315 -357 | -2% | -$10.5K |
|
314
Brown-Forman Class B
BF.B
$14.2B
| $535K | ﹤0.01% | 15,757 -83,055 | -84% | -$2.82M |
|
315
Unilever
UL
$155B
| $534K | ﹤0.01% | 8,970 -60 | -0.7% | -$3.57K |
|
316
Charles Schwab
SCHW
$174B
| $522K | ﹤0.01% | 6,666 | – | – |
|
317
Boeing
BA
$177B
| $516K | ﹤0.01% | 3,027 | – | – |
|
318
iShares Russell 3000 ETF
IWV
$16.6B
| $505K | ﹤0.01% | +1,590 | New | +$505K |
|
319
AT&T
T
$209B
| $482K | ﹤0.01% | 17,033 +94 | +0.6% | +$2.66K |
|
320
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $448K | ﹤0.01% | 7,391 | – | – |
|
321
Xylem
XYL
$34.5B
| $444K | ﹤0.01% | 3,718 +300 | +9% | +$35.8K |
|
322
GE Vernova
GEV
$167B
| $417K | ﹤0.01% | 1,365 -199 | -13% | -$60.8K |
|
323
Vanguard Real Estate ETF
VNQ
$34.6B
| $409K | ﹤0.01% | 4,522 | – | – |
|
324
Carlisle Companies
CSL
$16.5B
| $409K | ﹤0.01% | 1,200 | – | – |
|
325
AstraZeneca
AZN
$248B
| $402K | ﹤0.01% | 5,471 | – | – |
|